Skip to main content

Table 1 Participant characteristics

From: Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa

 

QUAL sample

Participants enrolled, N

214

Currently married

 

 Yes

96 (45%)

 No

118 (55%)

Highest level of education

 

 No schooling

5 (2%)

 Primary school (partial and complete)

45 (21%)

 Secondary school (partial and complete)

156 (73%)

 Attended college or university

8 (4%)

Primary partner knows of participation in the trial

 

 Yes

153 (72%)

 No

60 (28%)

 Not sure

Primary partner knows has been asked to use ring

 

 Yes

125 (59%)

 No

88 (41%)

 Not sure

Primary partner HIV status

 

 HIV positive

4 (2%)

 HIV negative

125 (59%)

 Participant does not know

84 (39%)

Had same primary partner for last 3 months

 

 Yes

206 (97%)

 No

7 (3%)

Current method of contraception

 

 Intrauterine device

25 (12%)

 Oral contraceptives

14 (7%)

 Injectable contraceptives

121 (57%)

  Depot medroxyprogesterone acetate (DMPA)

94 (78%)

   Norethisterone enanthate (NET-EN)

27 (22%)

 Hormonal implant

50 (23%)

 Sterilization

5 (2%)

Age, years

 

 Median (range)

26 (18–42) [213]